IndexCopernicus™ Authors Information
Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.
Amy D Klion, Jamie Robyn, Irina Maric, Weiming Fu, Laura Schmid, Steven Lemery, Pierre Noel, Melissa A Law, Marilyn Hartsell, Cheryl Talar-Williams, Michael P Fay, Cynthia E Dunbar, Thomas B Nutman
BLOOD 2007; 110(10):3552-3556
ICID: 786983
IC™ Value: 84.63
Author's profile available for:
  • Michael P Fay - click here